Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | ATP2C1 |
| Upstream (Parents) |
|---|
| (<<) ADORA2B → ATP2C1 |
| (<<) CLDN5 → ATP2C1 |
| (<<) CSGALNACT2 → ATP2C1 |
| (<<) DUSP10 → ATP2C1 |
| (<<) ENTPD7 → ATP2C1 |
| (<<) HDAC6 → ATP2C1 |
| (<<) HIPK1 → ATP2C1 |
| (<<) ITGA7 → ATP2C1 |
| (<<) ITGAV → ATP2C1 |
| (<<) KYNU → ATP2C1 |
| (<<) MAP6D1 → ATP2C1 |
| (<<) MAPK14 → ATP2C1 |
| (<<) ME1 → ATP2C1 |
| (<<) NDST1 → ATP2C1 |
| (<<) PDE2A → ATP2C1 |
| (<<) PDK2 → ATP2C1 |
| (<<) PLEK2 → ATP2C1 |
| (<<) PRSS2 → ATP2C1 |
| (<<) PRSS3 → ATP2C1 |
| (<<) RNF11 → ATP2C1 |
| (<<) SERPINB1 → ATP2C1 |
| (<<) TNXB → ATP2C1 |
| (<<) UBE2D1 → ATP2C1 |
| Downstream (Children) |
|---|
| ATP2C1 → BPGM (>>) |
| ATP2C1 → CSTA (>>) |
| ATP2C1 → CYP27B1 (>>) |
| ATP2C1 → GNG4 (>>) |
| ATP2C1 → GPNMB (>>) |
| ATP2C1 → IL1B (>>) |
| ATP2C1 → IRX2 (>>) |
| ATP2C1 → PDIA3 (>>) |
| ATP2C1 → PIK3CB (>>) |
| ATP2C1 → SOCS6 (>>) |
| ATP2C1 → STAM2 (>>) |
| ATP2C1 → TARSL2 (>>) |
| ATP2C1 → WNT5A (>>) |
